Publications by authors named "Camille N Abboud"

62Publications

Insights into the role of the JAK/STAT signaling pathway in graft--host disease.

Ther Adv Hematol 2020 2;11:2040620720914489. Epub 2020 Jun 2.

Virginia E. and Samuel J. Golman Professor, Chief, Division of Oncology, Deputy Director, Siteman Cancer Center, Washington University School of Medicine, 66o S. Euclid Avenue, CB 8007, Saint Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620720914489DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268158PMC
June 2020

Serendipity: decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia.

Haematologica 2019 04 7;104(4):e170-e173. Epub 2019 Feb 7.

BMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, MO

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.209478DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442953PMC
April 2019

Lack of a Prognostic Impact of the MyD88 L265P Mutation for Diffuse Large B Cell Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

Biol Blood Marrow Transplant 2017 Dec 26;23(12):2199-2204. Epub 2017 Aug 26.

Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.08.022DOI Listing
December 2017

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

N Engl J Med 2016 11;375(21):2023-2036

the Department of Internal Medicine, Division of Oncology (J.S.W., L.D.W., G.L.U., A.G., M.H.T., I.P., R.R., T.A.F., K.E.S.-G., R.V., S.T.O., C.N.A., A.F.C., M.A.S., M.A.J., S.E.H., K.L., M.R.J., M.J.W., P.W., D.C.L., J.F.D., T.J.L.), and the Division of Biostatistics (J.D.B.), and the Department of Pathology and Immunology (E.J.D., B.T., Y.-S.L.), Washington University School of Medicine, and McDonnell Genome Institute, Washington University in St. Louis (A.A.P., C.A.M., C.C.F., M.O., R.S.F., R.K.W., L.D.W., T.J.L.) - both in St. Louis; the Departments of Internal Medicine (A.H., N.K., M.J.S., W.S.) and Pharmacy (R.W.K.), University of Chicago, Chicago; and the Department of Internal Medicine (T.A.G.), Massachusetts General Hospital, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1605949DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217532PMC
November 2016

NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017.

J Natl Compr Canc Netw 2016 12;14(12):1505-1512

From St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Memorial Sloan Kettering Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; UC San Diego Moores Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; Stanford Cancer Institute; Fred & Pamela Buffett Cancer Center; Massachusetts General Hospital Cancer Center; Vanderbilt-Ingram Cancer Center; The University of Texas MD Anderson Cancer Center; Fox Chase Cancer Center; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute; Duke Cancer Institute; Roswell Park Cancer Institute; University of Colorado Cancer Center; University of Michigan Comprehensive Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; UCSF Helen Diller Family Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; City of Hope Comprehensive Cancer Center; Moffitt Cancer Center; Mayo Clinic Cancer Center; University of Wisconsin Carbone Cancer Center; National Comprehensive Cancer Network; Huntsman Cancer Institute at the University of Utah; and Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0162DOI Listing
December 2016

Leukostasis in adult acute hyperleukocytic leukemia: a clinician's digest.

Hematol Oncol 2016 Jun 27;34(2):69-78. Epub 2016 Mar 27.

Washington University School of Medicine, Department of Medicine, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2292DOI Listing
June 2016

Peritransplant Serum Albumin Decline Predicts Subsequent Severe Acute Graft-versus-Host Disease after Mucotoxic Myeloablative Conditioning.

Biol Blood Marrow Transplant 2016 06 14;22(6):1137-1141. Epub 2016 Mar 14.

Bone Marrow Transplantation and Leukemia Section, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.03.010DOI Listing
June 2016

Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F.

J Clin Oncol 2015 Nov 31;33(33):3953-60. Epub 2015 Aug 31.

Brady L. Stein, Northwestern Feinberg University School of Medicine, Chicago, IL; Stephen T. Oh and Camille Abboud, Washington University School of Medicine, St Louis, MO; Dmitriy Berenzon, Wake Forest University School of Medicine, Winston Salem, NC; Gabriela S. Hobbs, Massachusetts General Hospital, Boston, MA; Marina Kremyanskaya, John Mascarenhas, and Ronald Hoffman, Mount Sinai School of Medicine; Raajit K. Rampal, Memorial Sloan Kettering Cancer Center; Mark L. Heaney, Columbia University Medical Center; Ellen K. Ritchie, Cornell University School of Medicine, New York, NY; Kenneth Adler, Regional Cancer Care Associates, Morristown, NJ; Elias J. Jabbour, MD Anderson Cancer Center; Lawrence Rice, Cornell Houston Methodist Hospital, Houston, TX; Rami S. Komrokji, Moffitt Cancer Center, Tampa, FL; and Alison R. Moliterno, Johns Hopkins University School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/08/31/JCO.2015.61
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.61.6474
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.61.6474DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979103PMC
November 2015

Granulocyte colony–stimulating factor priming improves haploidentical stem cell transplantation in high-risk acute myeloid leukemia subsets: a new role for an old work horse.

Authors:
Camille N Abboud

Biol Blood Marrow Transplant 2014 Dec;20(12):1873-4

Division of Oncology, Section of Bone Marrow Transplant and Leukemia, Washington University in St Louis School of Medicine, Siteman Cancer Center, Saint Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.10.013DOI Listing
December 2014

Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia.

Am J Hematol 2014 May 3;89(5):487-92. Epub 2014 Mar 3.

Department of Medicine, Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St. Louis, Missouri.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23663DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378713PMC
May 2014

Chronic Myelogenous Leukemia, Version 1.2014.

J Natl Compr Canc Netw 2013 Nov;11(11):1327-40

From 1The University of Texas MD Anderson Cancer Center; 2Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 3Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 4Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 5Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 6Memorial Sloan-Kettering Cancer Center; 7Dana-Farber/Brigham & Women's Cancer Center; 8Huntsman Cancer Institute at the University of Utah; 9The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 10Massachusetts General Hospital Cancer Center; 11Stanford Cancer Institute; 12Vanderbilt-Ingram Cancer Center; 13Fox Chase Cancer Center; 14Duke Cancer Institute; 15St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 16Moffitt Cancer Center; 17University of Alabama at Birmingham Comprehensive Cancer Center; 18UCSF Helen Diller Family Comprehensive Cancer Center; 19The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 20City of Hope Comprehensive Cancer Center; 21Roswell Park Cancer Institute; and 22National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234105PMC
http://dx.doi.org/10.6004/jnccn.2013.0157DOI Listing
November 2013

Acute myeloid leukemia, version 2.2013.

J Natl Compr Canc Netw 2013 Sep;11(9):1047-55

From 1City of Hope Comprehensive Cancer Center; 2Memorial Sloan-Kettering Cancer Center; 3Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 4Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 5Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 6Stanford Cancer Institute; 7Massachusetts General Hospital Cancer Center; 8University of Alabama at Birmingham Comprehensive Cancer Center; 9UCSF Helen Diller Family Comprehensive Cancer Center; 10Moffitt Cancer Center; 11UNMC Eppley Cancer Center at The Nebraska Medical Center; 12The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 13St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 14Fox Chase Cancer Center; 15Duke Cancer Institute; 16The University of Texas MD Anderson Cancer Center; 17Huntsman Cancer Institute at the University of Utah; 18The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 19Dana-Farber Cancer Institute; 20Vanderbilt-Ingram Cancer Center; 21Roswell Park Cancer Institute; and 22National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161234PMC
http://dx.doi.org/10.6004/jnccn.2013.0127DOI Listing
September 2013

Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a phase I study.

Am J Hematol 2011 Sep 3;86(9):796-800. Epub 2011 Aug 3.

Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.22092DOI Listing
September 2011

Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation.

Biol Blood Marrow Transplant 2011 Nov 3;17(11):1646-52. Epub 2011 May 3.

Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, Department of Internal Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791110019
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2011.04.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166401PMC
November 2011

A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection.

Biol Blood Marrow Transplant 2011 Jul 11;17(7):1033-42. Epub 2010 Nov 11.

Hematology Oncology, University of Rochester Medical Center, James P. Wilmot Cancer Center, Strong Memorial Hospital, Rochester, New York 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.11.003DOI Listing
July 2011

A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia.

Blood 2011 Feb 4;117(6):1828-33. Epub 2010 Nov 4.

Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-07-297143DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318598PMC
February 2011

Cladribine in the treatment of acute myeloid leukemia: a single-institution experience.

Clin Lymphoma Myeloma 2009 Aug;9(4):298-301

Section of Leukemia and Bone Marrow Transplantation, Division of Oncology, Washington University School of Medicine, Saint Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2009.n.058DOI Listing
August 2009

Another nail in the AML coffin.

Authors:
Camille N Abboud

Blood 2009 Jun;113(24):6045-6

Washington University School of Medicine, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2009-03-18
Publisher Site
http://dx.doi.org/10.1182/blood-2009-03-189803DOI Listing
June 2009

Unlocking the dysplasia puzzle.

Authors:
Camille N Abboud

Blood 2008 Oct;112(8):3005-6

Washington University School of Medicine, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-06-160655DOI Listing
October 2008

Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13.

Blood 2009 Jan 29;113(5):1002-5. Epub 2008 Sep 29.

Department of Internal Medicine, Division of Oncology, Siteman Cancer Center, Washington University, St Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-04-152678DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947363PMC
January 2009

Rapid method for detection of mutations in the nucleophosmin gene in acute myeloid leukemia.

J Mol Diagn 2008 Jul 13;10(4):338-45. Epub 2008 Jun 13.

Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2353/jmoldx.2008.070175DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2438203PMC
July 2008

Induction therapy for elderly patients with acute myeloid leukemia.

Blood Rev 2008 Nov 9;22(6):311-20. Epub 2008 Jun 9.

Section of Bone Marrow Transplantation and Leukemia, Division of Medical Oncology, Siteman Cancer Center, Washington University in Saint Louis, MO 63110, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2008.04.004DOI Listing
November 2008

Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells.

Leuk Res 2007 Nov 2;31(11):1553-63. Epub 2007 Apr 2.

James P Wilmot Cancer Center and the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2007.02.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2133372PMC
November 2007

Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin.

Blood 2006 Apr 20;107(7):2895-903. Epub 2005 Dec 20.

Division of Nephrology, University of Rochester Medical Center, 601 Elmwood Ave, Box 675, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-06-2269DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895388PMC
April 2006

Acute myelogenous leukemia--microenvironment interactions: role of endothelial cells and proteasome inhibition.

Hematology 2005 Dec;10(6):483-94

University of Rochester, University of Rochester Medical Center, Department of Medicine and the James P. Wilmot Cancer Center, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10245330500233452DOI Listing
December 2005

Mini-BEAM and autologous hematopoietic stem-cell transplant for treatment of post-transplant lymphoproliferative disorders.

Am J Hematol 2005 Jul;79(3):211-5

Department of Medicine, University of Cincinnati and Veterans Administration Medical Center, Cincinnati, Ohio 45267, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.20334DOI Listing
July 2005

Donor cell myelodysplastic syndrome after allogeneic stem cell transplantation responding to donor lymphocyte infusion: case report and literature review.

Am J Hematol 2004 Aug;76(4):389-94

Department of Medicine, University of Rochester School of Medicine and Dentistry and James P. Wilmot Cancer Center, Rochester, New York 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.20111DOI Listing
August 2004

Flavonoid effects on normal and leukemic cells.

Leuk Res 2003 Jun;27(6):517-27

Department of Medicine, James P Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0145-2126(02)00265-5DOI Listing
June 2003

Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients.

Biol Blood Marrow Transplant 2002 ;8(12):662-5

Blood and Marrow Transplant Program, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/bbmt.2002.v8.abbmt080662DOI Listing
July 2003

Optimal cytokine stimulation for the enhanced generation of leukemic dendritic cells in short-term culture.

Leuk Res 2002 Feb;26(2):191-201

The University of Rochester Medical Center, Department of Internal Medicine, Hematology/Oncology Unit, Box 610, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0145-2126(01)00104-7DOI Listing
February 2002